Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / GNCA - Genocea Biosciences announces follow-up data from GEN-009 Neoantigen Vaccine phase 1/2a trial


GNCA - Genocea Biosciences announces follow-up data from GEN-009 Neoantigen Vaccine phase 1/2a trial

  • Genocea Biosciences (NASDAQ:GNCA) +11% announces follow up data from the first five patients vaccinated in Part B of the ongoing GEN-009 Phase 1/2a trial at the European Society for Medical Oncology Virtual Congress 2020.
  • More news on: Genocea Biosciences, Inc., Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Genocea Biosciences Inc.
Stock Symbol: GNCA
Market: NASDAQ

Menu

GNCA GNCA Quote GNCA Short GNCA News GNCA Articles GNCA Message Board
Get GNCA Alerts

News, Short Squeeze, Breakout and More Instantly...